Summary
Ciclosporin (CyA) and azathioprine were compared with respect to efficacy, safety and tolerance in rheumatoid arthritis. Twelve patients were treated with ciclosporin 10 mg/kg/day and 12 patients with azathioprine 2.5–3 mg/kg/day for 26 weeks in an open, controlled and randomized study. All patients received prednisolone 5 mg/day as basic therapy. Both groups demonstrated an improvement in the majority of clinical parameters. There was a tendency towards more improvement in the ciclosporin group than in the azathioprine group. At the end of the study the patients on ciclosporin used a lower prednisolone dose than those on azathioprine. Reduction in the C-reactive protein (CRP) levels was seen in both groups, while the sedimentation rate was augmented in the ciclosporin group and reduced in the azathioprine group compared to baseline levels.
Four of the patients on azathioprine and 2 of the patients on ciclosporin had to discontinue the treatment due to side effects and one of the patients on azathioprine had to discontinue due to an unacceptable increase in disease activity.
An increase in serum creatinine and potassium as well as in systolic and diastolic blood pressure compared with baseline values was observed in the ciclosporin group but not in the azathioprine group. These parameters returned to normal after termination of treatment, except for an irreversible augmentation in serum creatinine in one patient who had signs of renal dysfunction prior to therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adu D, Tumey J, Michael J, McMaster P (1983) Hyperkalaemia in cyclosporin-treated renal allograft recipients. Lancet 11:370
Borel JF, Wiesinger D, Gubler HV (1978) Effects of the antilymphocytic agent cyclosporin A in chronic inflammation. Eur J Rheum Inflam 1:237
Brater G, Anderson S, Baird B, Campbell W (1985) Effects of ibuprofen, aproxen and sulidac on prostaglandine in men. Kidney Int 27:66
Britton S, Palacios R (1982) Cyclosporin A. — Usefulness, risks and mechanism of action. Immunol Rev 65:5
Flechner SM, van Buren CT, Kahan BD (1983) Nephrotoxicity in renal recipients. Transplant Proc 15:2689
Ferre O, Egeland T, Waalen K, Mellbye OJ (1982) Interleukin 2 production by peripheral blood, synovial fluid and synovial tissue lymphocytes. Clin Rheumat 1 (abstr)
Granelli-Piperno A, Inoba K, Steinman RM (1984) Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by Cyclosporin A. J Exp Med 160:1792
Herrman B, Muller W (1979) Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunosuppressivum. Akt Rheumatol 4:173
Joss DV, Barrett AJ, Kendra JR (1982) Hypertension and convulsions in children receiving cyclosporin A. Lancet 11:906
Laupacis A (1983) Complications of cyclosporine therapy — a comparison to azathioprine. Transplant Proc 15:2748
Mingari MC, Gerasa F, Carra G, Accolla RS, Moretta A, Zubler RH, Waldman TA, Moretta L (1984) Human Interleukin 2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 312:641
Myers BD, Ross J, Neveton L, Leutcher J, Perlroth M (1984) Cyclosporine-associated chronic nephropathy. N Engl J Med 319:699
NIH Conference (1984) Rheumatoid Arthritis:Evolving concepts of pathogenesis and treatment. Ann Intern Med 101:810
Palestine AG, Nussenblatt RB, Chan CC (1984) Side effects of systemic cyclosporine in patients not undergoing transplantation. J Med 77:652
Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA (1958) 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175
Skjodt M, Gallagher JA, Beresford JN, El-ford P, Gowen M, Poser JW, Wood DD, Russell RGG (1984) Modulation of Interleukin-1-effects on bone by cyclosporine. Calcif Tissue ha 36 [Supp] 21:50 (Abstr)
Smith KA, Lachman LB, Oppenheim JJ, Fontana MF (1980) The functional relationship of interleukins. J Exp Med 151:1551
Wood DD, Ihrie EJ, Dinarello CA, Cohen PL (1983) Isolation of an Interleukin-l-like factor from human joint effusions. Arthritis Rheum 26:975
Zvaifler NJ (1973) The Immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Sandoz Ltd, Basle
About this paper
Cite this paper
Førre, O., Bjerkhoel, F., Rugstad, H.E., Berg, K.J., Kåss, E. (1985). Ciclosporin versus Azathioprine in Rheumatoid Arthritis. In: Schindler, R. (eds) Ciclosporin in Autoimmune Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70607-3_59
Download citation
DOI: https://doi.org/10.1007/978-3-642-70607-3_59
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70609-7
Online ISBN: 978-3-642-70607-3
eBook Packages: Springer Book Archive